Aclaris Therapeutics, Inc. – LSE:0H8T.L

Aclaris Therapeutics stock price today

$19.09
+16.33
+591.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

Aclaris Therapeutics stock price monthly change

+112.31%
month

Aclaris Therapeutics stock price quarterly change

+112.31%
quarter

Aclaris Therapeutics stock price yearly change

+162.86%
year

Aclaris Therapeutics key metrics

Market Cap
 211.81M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -1.09
Revenue
 31.11M
EBITDA
 -88.63M
Income
 -77.26M
Revenue Q/Q
 -5.14%
Revenue Y/Y
 0.94%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 -284.84%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Aclaris Therapeutics stock price history

Aclaris Therapeutics stock forecast

Aclaris Therapeutics financial statements

Profit Margin

Aclaris Therapeutics, Inc. (LSE:0H8T.L): Profit margin
Jun 2023 1.86M -29.56M -1582.08%
Sep 2023 9.28M -29.26M -315.24%
Dec 2023 17.57M -1.49M -8.49%
Mar 2024 2.39M -16.94M -706.46%
0H8T.L income statement history

Aclaris Therapeutics Financials Estimate

Aclaris Therapeutics, Inc. (LSE:0H8T.L): Analyst Estimates
Mar 2024 2.39M -16.94M -706.46%
Sep 2025 1.44M -18.42M -1275.99%
Oct 2025 4.06M -14.03M -345.43%
Dec 2025 6.43M -12.97M -201.45%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

Aclaris Therapeutics, Inc. (LSE:0H8T.L): Debt to assets
Jun 2023 235649000 55.89M 23.72%
Sep 2023 218354000 62.02M 28.4%
Dec 2023 199551000 42.37M 21.23%
Mar 2024 174065000 32.05M 18.41%
0H8T.L balance sheet history

Cash Flow

Aclaris Therapeutics, Inc. (LSE:0H8T.L): Cash Flow
Jun 2023 -20.65M -19.66M 26.74M
Sep 2023 -24.55M 32.53M -87K
Dec 2023 -6.76M 7.55M 49K
Mar 2024 -20.81M 16.83M -55K
0H8T.L cash flow history

Aclaris Therapeutics alternative data

Aclaris Therapeutics
Employees

Aclaris Therapeutics, Inc. (LSE:0H8T.L): Employee count
Aug 2023 100
Sep 2023 100
Oct 2023 100
Nov 2023 100
Dec 2023 100
Jan 2024 100
Feb 2024 100
Mar 2024 86
Apr 2024 86
May 2024 86
Jun 2024 86
Jul 2024 86

Aclaris Therapeutics other data

Frequently Asked Questions (FAQ)

  • What's the price of Aclaris Therapeutics stock today?

    One share of Aclaris Therapeutics stock can currently be purchased for approximately $19.09.

  • When is Aclaris Therapeutics's next earnings date?

    Unfortunately, Aclaris Therapeutics's (0H8T.L) next earnings date is currently unknown.

  • Does Aclaris Therapeutics pay dividends?

    No, Aclaris Therapeutics does not pay dividends.

  • How much money does Aclaris Therapeutics make?

    Aclaris Therapeutics has a market capitalization of 211.81M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5.03% to 31.25M US dollars.

  • What is Aclaris Therapeutics's stock symbol?

    Aclaris Therapeutics, Inc. is traded on the LSE under the ticker symbol "0H8T.L".

  • What is Aclaris Therapeutics's primary industry?

    Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.

  • How do i buy shares of Aclaris Therapeutics?

    Shares of Aclaris Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Aclaris Therapeutics have?

    As Jul 2024, Aclaris Therapeutics employs 86 workers.

  • When Aclaris Therapeutics went public?

    Aclaris Therapeutics, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.

  • What is Aclaris Therapeutics's official website?

    The official website for Aclaris Therapeutics is aclaristx.com.

  • Where are Aclaris Therapeutics's headquarters?

    Aclaris Therapeutics is headquartered at 640 Lee Road, Wayne, PA.

  • How can i contact Aclaris Therapeutics?

    Aclaris Therapeutics's mailing address is 640 Lee Road, Wayne, PA and company can be reached via phone at +48 43247933.

Aclaris Therapeutics company profile:

Aclaris Therapeutics, Inc.

aclaristx.com
Exchange:

LSE

Full time employees:

86

Industry:

Medical - Pharmaceuticals

Sector:

Healthcare

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

+48 43247933
640 Lee Road
Wayne, PA 19087

:
ISIN: US00461U1051
: